Novo Nordisk A/S (NVO)
44.24
+0.60 +1.37%
NYSE
Nov 21, 20:00
Delayed 2m
USD
View All Key Stats
NVO Key Stats
| Income Statement | |
| Revenue (TTM) | 17.59B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.523 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 6.146B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 84.10% |
| Profit Margin (Quarterly) | 32.55% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 106.21B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 6.132 |
| PE Ratio (TTM) | 17.53 |
| Price to Book Value | 14.37 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 1.272B |
| Return on Equity (TTM) | Upgrade |
View All NVO News
NVO News
-
WireHeadlineTime (ET)
-
Yahoo11/21 08:15
-
MT Newswires11/19 10:52
-
MT Newswires11/19 10:43
-
SA Breaking News11/16 09:33
-
MT Newswires11/15 11:14
-
Yahoo11/14 06:53
-
SA Breaking News11/13 09:43
-
Yahoo11/08 14:53
-
SA Breaking News11/02 07:04
-
MT Newswires11/02 06:38
View All Events
NVO Events
| Date | Type | Description |
|---|---|---|
| 08/08/2019 | Misc | Novo Nordisk A/S Second Quarter Earnings Conference Call in 2019 |
| 11/01/2018 | Earnings | Novo Nordisk A/S Third Quarter Earnings Results in 2018 |
| 08/17/2018 | Dividends | Amount: 0.4623, Declared Date: Aug 07 2018, Pay Date: Aug 28 2018 |
| 08/08/2018 | Earnings | Novo Nordisk A/S Second Quarter Earnings in 2018 Release |
| 08/08/2018 | Misc | Novo Nordisk A/S Second Quarter Earnings Conference Call in 2018 |
| 05/02/2018 | Earnings | Novo Nordisk A/S First Quarter Earnings Results in 2018 |
| 03/23/2018 | Dividends | Amount: 0.8060, Declared Date: Mar 13 2018, Pay Date: Apr 03 2018 |
| 02/08/2018 | Misc | Novo Nordisk A/S Annual Report in 2017 |
| 02/01/2018 | Earnings | Novo Nordisk A/S Fourth Quarter Earnings Results in 2017 |
NVO Fundamentals
Income Statement View Statement
NVO Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
NVO One Page Reports
- One Page Report Download
NVO Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 44.24 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.novonordisk.com
- Investor Relations URL: http://www.novonordisk.com/investors.html
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Large Cap/Growth
- Next Earnings Release: N/A
- Last Earnings Release: Nov. 01, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Aug. 17, 2018
- Description: Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company’s business segments include, diabetes and obesity care, and biopharmaceuticals.
NVO Excel Add-In Codes
- Name: =YCI("NVO","name")
- Description: =YCI("NVO","description")
- Sector: =YCI("NVO","sector")
- Industry: =YCI("NVO","industry")
- Est. Current Fiscal Year End: =YCI("NVO","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other NVO Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NVO Tweets Stocktwits
Advertisement
